
Nykode Therapeutics ASA
NYKD | OL
Overview
Corporate Details
- ISIN(s):
- NO0010714785
- LEI:
- 254900UKQHWYZJD22017
- Country:
- Norway
- Address:
- Gaustadalleen 21, 0349 Oslo
- Website:
- https://nykode.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Nykode Therapeutics is a leading clinical-stage biopharmaceutical company. With our intelligent modular platform and tailored hyper-targeting, we’re unlocking unlimited possibilities for the future of medicine. With our unique and innovative modular vaccine technology, we’re specifically targeting antigens to Antigen Presenting Cells, which are essential for inducing rapid, strong and long-lasting immune responses.
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
2025-05-28 07:00 |
Earnings Release
Nykode Therapeutics - Quarterly report Q1 2025 - Attachment: 250528 Nykode Quar…
|
English | 4.3 MB | |
2025-05-28 07:00 |
Quarterly Report
Nykode Therapeutics - Quarterly report Q1 2025
|
English | 3.0 KB | |
2025-05-27 07:00 |
Notice of Dividend Amount
Nykode Therapeutics ASA - Ex-dividend NOK 1.00 today
|
English | 490 bytes | |
2025-05-26 16:51 |
Report Publication Announcement
Nykode Therapeutics – invitation to Q1 2025 financial results presentation - A…
|
English | 125.5 KB | |
2025-05-26 16:51 |
Report Publication Announcement
Nykode Therapeutics – invitation to Q1 2025 financial results presentation
|
English | 3.2 KB | |
2025-05-26 11:25 |
Declaration of Voting Results & Voting Rights Announcements
Nykode Therapeutics ASA - Minutes of Annual General Meeting - Attachment: 25052…
|
English | 297.9 KB | |
2025-05-26 11:25 |
Declaration of Voting Results & Voting Rights Announcements
Nykode Therapeutics ASA - Minutes of Annual General Meeting
|
English | 2.8 KB | |
2025-05-23 05:00 |
Regulatory News Service
Nykode Therapeutics Highlights New Data in Two Poster Presentations at the 2025…
|
English | 176.1 KB | |
2025-05-23 05:00 |
Company Presentation
Nykode Therapeutics Highlights New Data in Two Poster Presentations at the 2025…
|
English | 6.4 KB | |
2025-05-05 06:30 |
General Meeting Notice
Nykode Therapeutics ASA - Notice of Annual General Meeting
|
Norwegian | 319.2 KB | |
2025-05-05 06:30 |
General Meeting Notice
Nykode Therapeutics ASA - Notice of Annual General Meeting
|
English | 1.0 KB | |
2025-04-29 05:00 |
Annual Report
Nykode Therapeutics - Annual Report 2024
|
English | 17.1 MB | |
2025-04-29 05:00 |
Annual Report
Nykode Therapeutics - Annual Report 2024
|
English | 10.6 MB | |
2025-04-29 05:00 |
Report Publication Announcement
Nykode Therapeutics - Annual Report 2024
|
English | 3.1 KB | |
2025-04-28 17:17 |
Notice of Dividend Amount
Nykode Therapeutics – Key information relating to proposed cash dividend
|
English | 2.9 KB |
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
No insider transactions recorded for this company. |
Peer Companies
Company | Country | Ticker | View | |
---|---|---|---|---|
![]() |
1NKEMIA | Spain | IKM | |
![]() |
2cureX AB | Sweden | 2CUREX | |
![]() |
4SC AG | Germany | VSC | |
![]() |
Abera Bioscience AB | Sweden | ABERA | |
![]() |
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
![]() |
AB Science | France | AB | |
![]() |
Acticor Biotech | France | ALACT | |
![]() |
Active Biotech | Sweden | ACTI | |
![]() |
AcuCort AB | Sweden | ACUC |